glp-1 microbiome GLP‐1 agonists and the gut microbiome: A bidirectional relationship - Kamath - 2026 - British Journal of Clinical Pharmacology Interplay of gut microbiota, glucagon-like
Description
More people achieved at least a 5% weight reduction, but the drug caused higher rates of mild-to-moderate gastrointestinal issues
2025;68(01):e20
Variability in enrollment might reflect local recruitment challenges or specific inclusion criteria, such as obesity or infertility in PCOS patients (Table 2)
The sustained effects of a dual GIP/GLP-1 receptor agonist, NNC0090-2746, in patients with type 2 diabetes
But that's not the point
Oral medications are also expected to be much less expensive to manufacture than injectable pens
